Artificial intelligence in cardiovascular medicine: clinical applications
Thomas F Lüscher,Florian A Wenzl,Fabrizio D'Ascenzo,Paul A Friedman,Charalambos Antoniades
DOI: https://doi.org/10.1093/eurheartj/ehae465
IF: 39.3
2024-08-22
European Heart Journal
Abstract:Clinical medicine requires the integration of various forms of patient data including demographics, symptom characteristics, electrocardiogram findings, laboratory values, biomarker levels, and imaging studies. Decision-making on the optimal management should be based on a high probability that the envisaged treatment is appropriate, provides benefit, and bears no or little potential harm. To that end, personalized risk–benefit considerations should guide the management of individual patients to achieve optimal results. These basic clinical tasks have become more and more challenging with the massively growing data now available; artificial intelligence and machine learning (AI/ML) can provide assistance for clinicians by obtaining and comprehensively preparing the history of patients, analysing face and voice and other clinical features, by integrating laboratory results, biomarkers, and imaging. Furthermore, AI/ML can provide a comprehensive risk assessment as a basis of optimal acute and chronic care. The clinical usefulness of AI/ML algorithms should be carefully assessed, validated with confirmation datasets before clinical use, and repeatedly re-evaluated as patient phenotypes change. This review provides an overview of the current data revolution that has changed and will continue to change the face of clinical medicine radically, if properly used, to the benefit of physicians and patients alike. Clinical information including patient data, laboratory parameters, and results from clinical examination, large-scale data from (multi-)national registries, imaging data, and (patient) biometrical data can all be processed by artificial intelligence. Resulting models allow for disease phenotyping, enhance diagnostics, improve prognostication, and facilitate treatment decision-making, thus ultimately contributing to a more personalized therapy of patients with cardiovascular disease.
cardiac & cardiovascular systems